The Icahn School of Medicine at Mount Sinai has launched its Expanded Carrier Screening Panel for people of Ashkenazi Jewish descent. The panel screens for 38 diseases, up from 20 in a previous version.
Foundation Medicine's FoundationOne test has attained a CE mark, enabling it to be placed on the market in the European Economic Area.